Insider at

04

Insider transactions

05
0 buys (P) 0 sells (S) Net: $0 + 5 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

No open-market trades on record; showing all filings.

DateTickerCodeSharesPriceValue Owned afterΔ ownA/Dvs now
March 29, 2024 NXTC A 93,900 · · 93,900 Direct · Acquired (price as of 2026-10-06)
Jan. 31, 2024 NXTC A 117,375 · · 117,375 Direct · Acquired (price as of 2026-10-06)
Feb. 28, 2023 NXTC A 135,000 · · 135,000 Direct · Acquired (price as of 2026-10-06)
Jan. 31, 2022 NXTC A 103,600 · · 103,600 Direct · Acquired (price as of 2026-10-06)
Jan. 13, 2021 NXTC A 200,000 · · 200,000 Direct · Acquired (price as of 2026-10-06)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.

06
DateTickerSecurityUnderlying Exercise priceExpirationSharesA/D
March 29, 2024 NXTC Employee Stock Option (Right to Buy) Common Stock (93,900) $2.23 March 28, 2034 93,900 Acquired
Jan. 31, 2024 NXTC Employee Stock Option (Right to Buy) Common Stock (117,375) $1.22 Jan. 30, 2034 117,375 Acquired
Feb. 28, 2023 NXTC Employee Stock Option (Right to Buy) Common Stock (135,000) $1.55 Feb. 27, 2033 135,000 Acquired
Jan. 31, 2022 NXTC Employee Stock Option (Right to Buy) Common Stock (103,600) $5.57 Jan. 30, 2032 103,600 Acquired
Jan. 13, 2021 NXTC Employee Stock Option (Right to Buy) Common Stock (200,000) $12.09 Jan. 12, 2031 200,000 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Compensation (DEF 14A)

08

Matched by name from proxy statements (DEF 14A) — verify against the filing.

NXTC

M.D., FACP(5) former Chief Medical Officer
Fiscal yearSalaryBonusStock awards Option awardsNon-equity incentivePension changeOtherTotal
2023 $461,963 · · $151,269 $68,800 · $15,900 $697,932
2022 $445,413 · · $398,860 $98,200 · $10,845 $953,318
2021 $415,341 $75,000 · $1,650,000 $119,600 · $2,041 $2,261,982

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.